Kevin C. Johnson, Ph.D.

Postdoctoral Associate

Farmington, CT

Leverages genomic technologies to investigate brain tumor biology and disease evolution.

Visit The Verhaak Lab

Connect with me:

About Kevin C. Johnson, Ph.D.

Dr. Johnson has a Ph.D. in Experimental and Molecular Medicine from Dartmouth where he received comprehensive training in quantitative and basic biomedical sciences. He has strong interest in the dynamic epigenomic landscape of glioma cells during disease progression and recurrence.

DOWNLOAD CV

Education and Experience

2016 – present Postdoctoral Research Fellow

The Jackson Laboratory for Genomic Medicine

2011 – 2016 Ph.D., Experimental and Molecular Medicine

Dartmouth College

2007 – 2011 B.S., Food Science and Technology,

University of Massachusetts – Amherst

Honors and Accomplishments

2016 Neukom Prize for Outstanding Graduate Research in Computational Science

Albert J. Ryan Predoctoral Fellowship

Selected Publications

View Full List of Publications

Tech CornerMay 04, 2018
What's new in cancer research?
The field of cancer immunotherapy research is extremely exciting, yet still somewhat mysterious, as researchers grapple with the fine-tuning of patient response.
- Cancer/Tumors
- Cancer
Search MagazineApril 27, 2018
Finding precise cures for cancer
At JAX's new speaker event series, JAXtaposition, two scientific leaders shared how the Maine Cancer Genomics Initiative and JAX’s cutting-edge genomic testing is giving physicians access to the most advanced precision cancer care for their patients.
- Cancer/Tumors
- Cancer
Tech CornerApril 10, 2018
Cancer and its immune environment bioprinted and reproduced live and in 3D
New 3D bioprinting technique creates a platform for precision immunotherapy study.
Tech CornerApril 05, 2018
Finding the signal in the noise
GeneWeaver is a powerful web-based software system that combines a genomics data repository with powerful analysis tools.
- Genetic Tools
- Genetics and Genomics

Press ReleaseApril 30, 2018
Detecting human genome structural variation with long read sequencing
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
- Genetic Tools
- Genetics and Genomics
Press ReleaseApril 23, 2018
The role of extra DNA in cancer evolution and therapy resistance
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
- Cancer/Tumors
- Cancer
Research HighlightApril 10, 2018
Cancer research: Beyond the Petri dish
The latest developments in cancer research and their translation to oncology practice offer truly exciting potential for better therapies in the near future.
Press ReleaseApril 05, 2018
DNA sequence alterations linked to type 2 diabetes genes and mechanisms
Michael Stitzel, Ph.D., a Jackson Laboratory assistant professor, is the senior author of a paper in the American Journal of Human Genetics identifying new genetic clues to type 2 diabetes mechanisms.